B

Bellerophon Therapeutics

29 employees

Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2014

Funding rounds raised

Total raised

$80M

from 5 investors over 5 rounds

B

Bellerophon Therapeutics raised $80M on December 26, 2013

Investors: 5AM Ventures, Victory Schools, Inc. and New Mountain Capital, LLC, Venrock, Aravis and ARCH Venture Partners

FAQ